Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Spina Bifida Occulta 1Neural Tube Defects 1Neoplasms 1Lipomyelomeningocele 1Cerebrospinal Fluid Leak 1Breast Neoplasms 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × OTHER × Prone Position × Clear all
NCT02237469 2022-12-21

HUGProne

University Hospital, Geneva

Unknown
280 enrolled
Breast

Breast Neoplasms

NCT01867268 2015-04-21

Effect of Acetazolamide & Position in CSF Leakage and Collection and Wound Dehiscence

Tehran University of Medical Sciences

Phase 2 Unknown
144 enrolled

Lipomyelomeningocele, Neoplasms, Neural Tube Defects, Spina Bifida Occulta, Cerebrospinal Fluid Leak

Data powered by HemOnc (CC BY 4.0) Colophon âš¡